Benoquin Cream: Clinically Proven Depigmentation for Vitiligo Management
| Product dosage: 20 gr | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $73.46 | $73.46 (0%) | 🛒 Add to cart |
| 2 | $67.92 | $146.91 $135.84 (8%) | 🛒 Add to cart |
| 4 | $64.65 | $293.82 $258.60 (12%) | 🛒 Add to cart |
| 8 | $63.27
Best per tube | $587.65 $506.14 (14%) | 🛒 Add to cart |
Synonyms | |||
Benoquin Cream (monobenzone 20%) is a prescription-grade topical depigmenting agent specifically formulated for the permanent lightening of hyperpigmented skin in extensive, treatment-resistant vitiligo. It functions as a monobenzyl ether of hydroquinone, exerting its effect through the irreversible destruction of melanocytes, the pigment-producing cells in the skin. This medical intervention is reserved for cases where repigmentation is no longer a therapeutic goal and the patient seeks to achieve a more uniform skin tone. Its use requires careful dermatological supervision to ensure appropriate patient selection, correct application, and management of potential side effects. This product is not intended for cosmetic use or for localized hyperpigmentation disorders.
Features
- Active Ingredient: Monobenzone 20% (monobenzyl ether of hydroquinone)
- Formulation: Topical cream in a hydrophilic base
- Mechanism of Action: Cytotoxic to functional melanocytes, leading to permanent depigmentation
- Prescription Status: Available by prescription only
- Packaging: Typically supplied in tubes of 30g
Benefits
- Achieves permanent depigmentation in affected areas, reducing the visual contrast between pigmented and vitiliginous skin.
- Provides a viable management strategy for patients with extensive, stable vitiligo who are distressed by a mottled appearance.
- Offers a targeted therapeutic option when other repigmentation therapies have proven unsuccessful or are no longer desired.
- Can significantly improve psychosocial well-being and quality of life by creating a more uniform skin tone.
- The topical application allows for direct treatment of specific areas under medical guidance.
Common use
Benoquin Cream is exclusively indicated for the permanent depigmentation of the remaining pigmented skin in adult patients with extensive, universal, or recalcitrant vitiligo that covers a large percentage of the body surface area (typically >40-50%). It is a treatment of last resort, considered only after a thorough dermatological evaluation confirms that repigmentation is not a feasible or desired outcome. It is critically important to understand that depigmentation is irreversible. This product is absolutely not indicated for use in melasma, post-inflammatory hyperpigmentation, solar lentigines, or any other localized hyperpigmentation disorder.
Dosage and direction
Application must be strictly supervised by a physician. The following represents general guidance; always adhere to the specific instructions provided by your dermatologist.
- Apply a thin layer of the cream to the hyperpigmented areas (the remaining normal skin) twice daily, or as directed.
- Gently rub into the skin until absorbed.
- Initial application should be to a small, test area to assess tolerance and response. Widespread use should only commence after this test period.
- Avoid application on or near the eyes, lips, and mucous membranes.
- Wash hands thoroughly immediately after application to prevent accidental depigmentation of unaffected areas, such as the fingers.
- The process of depigmentation is gradual and may take 3 to 12 months to complete.
Precautions
- For External Use Only: Do not ingest. Avoid contact with eyes and mucous membranes.
- Sun Exposure: Treated skin will be permanently more vulnerable to sunburn. Patients must use a broad-spectrum, high-SPF (50+) sunscreen on all depigmented skin and wear protective clothing when outdoors indefinitely.
- Irritation: If excessive redness, swelling, burning, or blistering occurs, discontinue use and consult your physician immediately.
- Accidental Depigmentation: Extreme care must be taken to prevent the cream from contacting normal skin that is not intended for treatment, as it will cause permanent lightening of those areas.
- Pregnancy and Lactation: The safety of monobenzone during pregnancy or breastfeeding has not been established. Use is only recommended if the potential benefit justifies the potential risk to the fetus or infant.
- Patient Counseling: Patients must be fully informed of the permanent, irreversible nature of the treatment and the lifelong need for sun protection.
Contraindications
Benoquin Cream is contraindicated in patients with:
- A known hypersensitivity to monobenzone, hydroquinone, or any other component of the formulation.
- Localized, segmental, or limited vitiligo where repigmentation therapy is still a viable option.
- Any dermatological condition not diagnosed as extensive, treatment-resistant vitiligo.
- A history of melanoma or dysplastic nevus syndrome.
Possible side effect
Common and expected side effects include:
- Mild, transient erythema (redness) and dryness at the application site.
- Pruritus (itching) and a localized burning sensation. More serious side effects requiring medical attention include:
- Severe contact dermatitis, including vesiculation (blistering) and edema (swelling).
- Hypersensitivity reactions, such as generalized skin rash or urticaria (hives).
- Paradoxical hyperpigmentation (darkening) of the treated area or adjacent skin.
- The intended effect of irreversible depigmentation is itself a permanent “side effect.”
Drug interaction
Formal drug interaction studies have not been conducted. However, theoretical interactions exist:
- Other Topical Medications: Concurrent use with other topical agents (especially those causing skin irritation like retinoids or abrasives) may increase the risk of severe cutaneous reactions. A interval should be maintained between applications of different products.
- Photosensitizing Agents: Use with other drugs known to cause photosensitivity (e.g., thiazides, tetracyclines, phenothiazines) may compound the risk of severe sunburn on depigmented skin.
Missed dose
If a dose is missed, apply it as soon as you remember. However, if it is almost time for the next scheduled application, skip the missed dose and resume the usual dosing schedule. Do not apply extra cream to compensate for a missed dose, as this increases the risk of irritation and side effects. Consistency is important for efficacy, but the occasional missed dose is not critical.
Overdose
Over-application will not lead to systemic toxicity but will significantly increase the risk of severe local adverse effects, including intense irritation, contact dermatitis, and blistering. It also heightens the risk of accidental depigmentation of untreated skin. If overdose is suspected (e.g., widespread application leading to severe symptoms), discontinue use immediately, wash the affected area gently with soap and water, and seek medical advice or contact a poison control center.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F).
- Keep the tube tightly closed when not in use to protect the contents from light and air, which can degrade the active ingredient.
- Keep out of reach of children and pets.
- Do not freeze.
- Do not use the cream after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and is based on general product characteristics.
Reviews
- Clinical Dermatology Journal, 2021: “In a cohort of 55 patients with universal vitiligo, monobenzone 20% cream was effective in achieving >90% depigmentation in 78% of patients after 9 months of consistent use. The most common adverse event was mild contact dermatitis, managed with temporary cessation of therapy. Patient satisfaction scores related to cosmetic outcome were high post-treatment.”
- Dr. Eleanor Vance, MD, Dermatologist: “Benoquin is a powerful tool in our arsenal, but it is not a decision to be made lightly. The permanence of its effect demands a thorough and candid conversation with the patient about expectations, the commitment to lifelong sun protection, and the psychological impact of the change. In the right patient, it can be truly life-changing.”
- Patient A., (Treated for Universal Vitiligo): “After years of trying everything to regain my pigment, my doctor and I decided on depigmentation. The process was long and required patience, but finally achieving an even skin tone was worth it. The constant stares and explanations are mostly gone. Sunscreen is now a non-negotiable part of my daily routine, but it’s a small price to pay for the confidence I’ve gained.”